You're reading the free version. Trader adds the live tape and alerts.
Start tracking
RPRX Sale Disclosure
Urist Marshall · SEC Form 4 · Filed Oct 5, 2026
Sale
Calculated transaction value
$235.59K
Urist Marshall EVP, Research & Investments
RPRX
Transaction date
Oct 5, 2026
Public filing date
Oct 5, 2026
Filing lag
Filed same day
RPRX daily price context
Close on/before transaction
$56.66
Oct 5, 2026
First close after public filing
$56.44
Oct 6, 2026
30-day return after filing
+19.7%
Through Nov 4, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Class A Ordinary Shares
- Quantity / price
- 4,126 shares @ $57.1
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001838139-26-000028
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$235.59K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Royalty Pharma Plc RPRX Current | Sale | Oct 5, 2026 | $235.59K |